| Primary |
| Parkinson's Disease |
79.1% |
| Hypertension |
3.0% |
| Sleep Disorder |
2.4% |
| Anxiety |
2.1% |
| Depression |
1.5% |
| Diabetes Mellitus |
1.5% |
| Hypothyroidism |
1.2% |
| Blood Pressure |
0.9% |
| Dementia Alzheimer's Type |
0.9% |
| Gastric Disorder |
0.9% |
| Pain |
0.9% |
| Tremor |
0.9% |
| Balance Disorder |
0.6% |
| Benign Prostatic Hyperplasia |
0.6% |
| Cerebral Hypoperfusion |
0.6% |
| Nervous System Disorder |
0.6% |
| Oedema Peripheral |
0.6% |
| Off Label Use |
0.6% |
| Panic Attack |
0.6% |
| Abdominal Discomfort |
0.3% |
|
| Death |
13.0% |
| Pneumonia |
13.0% |
| Wrong Technique In Drug Usage Process |
10.4% |
| Tremor |
9.6% |
| Parkinson's Disease |
7.8% |
| Hip Fracture |
4.3% |
| Respiratory Arrest |
4.3% |
| Product Quality Issue |
3.5% |
| Psychomotor Hyperactivity |
3.5% |
| Syncope |
3.5% |
| Urinary Tract Infection |
3.5% |
| Cataract |
2.6% |
| Cerebrovascular Accident |
2.6% |
| Infarction |
2.6% |
| Nausea |
2.6% |
| Pathological Gambling |
2.6% |
| Stress |
2.6% |
| Treatment Noncompliance |
2.6% |
| Vomiting |
2.6% |
| Weight Decreased |
2.6% |
|
| Secondary |
| Parkinson's Disease |
62.5% |
| Product Used For Unknown Indication |
7.6% |
| Sleep Disorder |
4.9% |
| Diabetes Mellitus |
3.6% |
| Depression |
2.6% |
| Dementia Alzheimer's Type |
2.0% |
| Hypothyroidism |
2.0% |
| Anxiety |
1.6% |
| Bipolar Disorder |
1.6% |
| Hypertension |
1.6% |
| Blood Pressure |
1.0% |
| Cardiac Disorder |
1.0% |
| Gastric Disorder |
1.0% |
| Gastrointestinal Disorder |
1.0% |
| Nervous System Disorder |
1.0% |
| Off Label Use |
1.0% |
| Osteoporosis |
1.0% |
| Pain |
1.0% |
| Parkinsonism |
1.0% |
| Tremor |
1.0% |
|
| Wrong Technique In Drug Usage Process |
10.9% |
| Pneumonia |
9.4% |
| Tremor |
9.4% |
| Suicidal Ideation |
7.8% |
| Parkinson's Disease |
6.3% |
| Weight Decreased |
6.3% |
| Hip Fracture |
4.7% |
| Petit Mal Epilepsy |
4.7% |
| Unresponsive To Stimuli |
4.7% |
| Withdrawal Syndrome |
4.7% |
| Death |
3.1% |
| Dystonia |
3.1% |
| Mania |
3.1% |
| Psychomotor Skills Impaired |
3.1% |
| Psychotic Disorder |
3.1% |
| Respiratory Arrest |
3.1% |
| Serotonin Syndrome |
3.1% |
| Spinal Pain |
3.1% |
| Stress |
3.1% |
| Subcutaneous Haematoma |
3.1% |
|
| Concomitant |
| Parkinson's Disease |
55.2% |
| Product Used For Unknown Indication |
16.4% |
| Depression |
4.0% |
| Chronic Obstructive Pulmonary Disease |
3.7% |
| Hypertension |
3.5% |
| Nervousness |
3.0% |
| Osteoporosis |
1.5% |
| Anxiety Disorder |
1.3% |
| Atrial Fibrillation |
1.3% |
| Anxiety |
1.2% |
| Hallucination |
1.2% |
| Coronary Artery Disease |
1.0% |
| Pain |
1.0% |
| Cancer Pain |
0.8% |
| Dementia Alzheimer's Type |
0.8% |
| Diabetes Mellitus |
0.8% |
| Non-hodgkin's Lymphoma |
0.8% |
| Schizophrenia |
0.8% |
| Tremor |
0.8% |
| Hypercholesterolaemia |
0.7% |
|
| Parkinson's Disease |
12.7% |
| Serotonin Syndrome |
8.5% |
| Tremor |
8.5% |
| Pathological Gambling |
7.0% |
| Drug Therapy Changed |
5.6% |
| Off Label Use |
5.6% |
| Rash |
5.6% |
| Death |
4.2% |
| Orthostatic Hypotension |
4.2% |
| Product Formulation Issue |
4.2% |
| Product Substitution Issue |
4.2% |
| Somnolence |
4.2% |
| Urinary Tract Infection |
4.2% |
| White Blood Cell Count Increased |
4.2% |
| Cataract Nuclear |
2.8% |
| Colorectal Cancer Stage Ii |
2.8% |
| Contusion |
2.8% |
| Diarrhoea |
2.8% |
| Dyskinesia |
2.8% |
| Fractured Sacrum |
2.8% |
|
| Interacting |
| Parkinson's Disease |
60.0% |
| Product Used For Unknown Indication |
26.7% |
| Erectile Dysfunction |
6.7% |
| Major Depression |
6.7% |
|
| Delirium |
40.0% |
| Parkinson's Disease |
20.0% |
| Pathological Gambling |
20.0% |
| Serotonin Syndrome |
20.0% |
|
